Enjoy complimentary customisation on priority with our Enterprise License!
Chondroitin Sulfate Market is projected to grow by USD 227.43 million with a CAGR of 4%, during the forecast period 2020 to 2025.
This chondroitin sulfate market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers chondroitin sulfate market segmentations by application (nutraceuticals, pharmaceuticals, animal feed, and personal care) and geography (APAC, North America, Europe, South America, and MEA). The chondroitin sulfate market report also offers information on several market vendors, including Aoxing Biotechnology Intl Co. Ltd., Arnet Pharmaceutical Corp., BeiJing Geyuantianrun Bio tech Co. Ltd., Jiaxing Hengjie Biopharmaceutical Co. Ltd., Pacific Rainbow International Inc., Seikagaku Corp., Shandong Focuschem Biotech Co. Ltd., Solabia Group, Summit Nutritionals International Inc., and Synutra International Inc. among others.
Download Report Sample to Unlock the Chondroitin Sulfate Market Size for the Forecast Period and Other Important Statistics
Our researcher studied the historical data for years, with 2020 as the base year, and 2021 as the estimated year, and produced drivers, trends and challenges for the chondroitin sulfate market. In the COVID-19 pandemic, the demand of chondroitin sulfate market has impacted a lot accelerating but with a holistic analysis of drivers will help in exact demands and refining marketing strategies to gain a competitive advantage.
Key Chondroitin Sulfate Market Driver
One of the key factors driving growth in the chondroitin sulfate market is the growing prevalence of OA. OA is a degenerative joint disease, which is the most common form of arthritis affecting the majority of the population worldwide. Globally, more than 15% of adults aged over 60 years have OA, with the prevalence being higher among women than in men. In the US, more than 20% of adults above 18 years of age are diagnosed with OA, among which around 40%-45% of individuals have limitations in their usual activities because of arthritis problems. Generally, with ageing, water content increases in cartilage and protein production decrease in the body, which results in cartilage degeneration and leads to OA. The number of people above 80 years of age is expected to triple by the end of 2050 as compared to that in 2019. With the expansion of the ageing population, the prevalence of OA is expected to increase significantly, which is expected to propel the demand for CS during the forecast period. Growing demand for dietary supplements
Key Chondroitin Sulfate Market Challenge
The stringent government regulations will be a major challenge for the chondroitin sulfate market during the forecast period. The global CS market operates under a high regulatory environment. The market is highly regulated in the US, Australia, France, and Germany. The US Food and Drug Administration (FDA) regulates the manufacturing and safety of food products, which includes CS. Dietary supplements, including CS, are prone to contamination owing to their manufacturing process using animal cartilage. The US, Canada, and Germany have witnessed a growth in labelling violations related to CS, which has led manufacturers to carefully examine the content of products and state the nutritional benefits to avoid any discrepancies in the statements. As CS is manufactured from animal cartilage, such as sharks, cows, and porcine, the government has also imposed strict regulations on the manufacturing process of CS to ensure the safety standards and quality of products.
This chondroitin sulfate market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.
Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the chondroitin sulfate market during the forecast period.
The report analyzes the market’s competitive landscape and offers information on several market vendors, including:
This statistical study of the chondroitin sulfate market encompasses successful business strategies deployed by the key vendors. The chondroitin sulfate market is fragmented and the vendors are deploying growth strategies such as pricing and marketing strategies to compete in the market.
Aoxing Biotechnology Intl Co. Ltd. - The company offers various chondroitin sulfate products such as Chondroitin Sulfate C 90% or 95% or 98% by CPC or HPLC.
Aoxing Biotechnology Intl Co. Ltd. - Under the unified segment, this company provides various category products such as Chitin, Chitosan and Glucosamine, Amino Acid, other Marine Biochemical Products, and Chondroitin Sulfate.
To make the most of the opportunities and recover from the post-COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The chondroitin sulfate market report contains a comprehensive market knowledge and in-depth vendor landscape add-on to an analysis of the key vendors.
Our In-house experts produce extensive information on the value chain, and parent market of the chondroitin sulfate market which vendors can leverage to gain a competitive advantage during the forecast period. The Value Chain information provides an end-end understanding of product insight and profit and also optimization and evaluation of business strategies The players across the value chain includes selective data and analysis from entire research findings as per the scope of the report.
For more insights on the market share of various regions Request PDF Sample now!
41% of the market’s growth will originate from APAC during the forecast period. China and Japan are the key markets for chondroitin sulfate in APAC. Market growth in this region will be faster than the growth of the market in other regions.
APAC is expected to witness a growth in the number of people with cataracts, owing to the lack of awareness and cataract health services in countries such as India, Indonesia, Vietnam, and Pakistan. This will facilitate the chondroitin sulfate market growth in APAC over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
Currently, the region is witnessing a surge in COVID-19 cases, specifically in India, with the outbreak of the second wave. As of May 23, 2021, the country registered over 26 million COVID-19 cases. The rising number of cases is augmenting the necessity for protein-based supplements and medicines to increase immunity. Therefore, owing to these factors, the demand for CS is expected to grow significantly in the region during the forecast period.
To gain further insights on the market contribution of various segments Request a PDF Sample
The chondroitin sulfate market share growth by the nutraceuticals segment will be significant during the forecast period. The growing adoption of healthy diets in food and the rising awareness about the importance of maintaining a healthy lifestyle are the major factors that drive the growth of this segment. Nutraceuticals are major therapeutic agents that help in curing OA. CS is one of the major constituent chemicals in nutraceuticals and is generally used in combination with collagen and glucosamine.
This report provides an accurate prediction of the contribution of all the segments to the growth of the chondroitin sulfate market size and actionable market insights on post-COVID-19 impact on each segment.
Chondroitin Sulfate Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2020 |
Forecast period |
2021-2025 |
Growth momentum & CAGR |
Accelerate at a CAGR of 4% |
Market growth 2021-2025 |
$ 227.43 million |
Market structure |
Fragmented |
YoY growth (%) |
3.21 |
Regional analysis |
APAC, North America, Europe, South America, and MEA |
Performing market contribution |
APAC at 41% |
Key consumer countries |
US, China, Germany, France, and Japan |
Competitive landscape |
Leading companies, Competitive Strategies, Consumer engagement scope |
Key companies profiled |
Aoxing Biotechnology Intl Co. Ltd., Arnet Pharmaceutical Corp., BeiJing Geyuantianrun Bio tech Co. Ltd., Jiaxing Hengjie Biopharmaceutical Co. Ltd., Pacific Rainbow International Inc., Seikagaku Corp., Shandong Focuschem Biotech Co. Ltd., Solabia Group, Summit Nutritionals International Inc., and Synutra International Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Application
Customer landscape
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.